Clinical Trial Update: Encapsulated Cell Biodelivery of Nerve Growth Factor to Alzheimer´s Disease Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating encapsulated cell biodelivery of nerve growth factor for Alzheimer's disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Nerve Growth Factor (NGF) (nerve growth factor)

Snippet

Sponsor: NsGene A/S | Conditions: Alzheimer's Disease | Phase 1 | Status: UNKNOWN